C.E.Management Integrated Laboratory Co., Ltd. (6171) AI Stock Analysis

• Market Cap: ¥6.45B
• Dividend Yield: 2.65%
• Average Volume (3M): 258.84K
• Price to Earnings (P/E): 18.1
• Beta (1Y): 0.40
• Revenue Growth: 2.77%
• EPS Growth: 96.98%
• Country: JP
• Employees: 525
• Sector: Industrials
• Sector Strength: 75
• Industry: Engineering & Construction
• EPS (TTM): 2.21
• Shares Outstanding: 14,237,995
• 10 Day Avg. Volume: 457,460
• 30 Day Avg. Volume: 258,836
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥510.00
• Price Target Upside: 12.58% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 77 Outperform
• Price Target: ¥510.00 ▲(12.58% Upside)

The company's strong financial performance is the most significant factor, supported by robust revenue growth and efficient profit margins. Technical analysis indicates positive momentum, although caution is advised due to slightly overbought conditions. The valuation is fair, with a reasonable P/E ratio and an attractive dividend yield. The absence of recent earnings call data and corporate events means these factors do not influence the score.

C.E.Management Integrated Laboratory Co., Ltd. Business Overview & Revenue Model

Company Description

C.E.Management Integrated Laboratory Co., Ltd. (6171) is a company that operates within the integrated laboratory and testing services sector. The company specializes in providing comprehensive laboratory testing, analysis, and consulting services to a variety of industries, including pharmaceuticals, environmental, food safety, and chemical manufacturing. Their core services encompass product testing, quality assurance, regulatory compliance testing, and certification, helping clients ensure product safety and meet industry standards.

How the Company Makes Money

The company generates revenue primarily through service fees charged for its extensive range of laboratory testing and consulting services. Key revenue streams include fees for routine and specialized product testing, quality assurance audits, and compliance certification services. The company may also have strategic partnerships with industrial firms, regulatory bodies, and research institutions that contribute to its revenue through long-term service contracts and collaborative projects. Additionally, by maintaining high standards of accuracy and reliability in testing, the company attracts repeat business from clients across diverse sectors seeking to ensure product safety and compliance.

C.E.Management Integrated Laboratory Co., Ltd. Financial Statement Overview

Summary

C.E.Management Integrated Laboratory Co., Ltd. demonstrates strong financial health with consistent revenue growth, efficient profit margins, and a solid balance sheet with low leverage. While cash flow generation is strong, variability in free cash flow growth due to fluctuating investments is a point to monitor. Overall, the company is well-positioned financially within its industry.

Income Statement

The company shows strong and consistent revenue growth over the years, with a notable increase from 2020 to 2024. Gross profit margins are healthy, and there is a consistent improvement in EBIT and EBITDA margins. The net profit margin has improved significantly, indicating better cost management and operational efficiency.

Balance Sheet

The company's balance sheet is robust with a high equity ratio, showing strong equity financing. The debt-to-equity ratio is low, indicating minimal leverage risk. ROE is healthy, reflecting efficient use of equity in generating profits. The overall financial stability is commendable, although there is room for improving asset utilization.

Cash Flow

The cash flow position is strong, with consistent free cash flow generation and a positive operating cash flow to net income ratio. However, free cash flow growth has fluctuated, showing some volatility in capital expenditures and investing activities. The company maintains a solid cash reserve, enhancing liquidity.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	7.35B	7.33B	7.00B	7.34B	6.21B
Gross Profit	2.87B	2.74B	2.65B	2.53B	2.05B
EBITDA	919.26M	739.14M	921.58M	801.64M	771.13M
Net Income	362.56M	190.06M	349.82M	213.30M	293.04M
Balance Sheet
Total Assets	7.03B	6.86B	7.00B	6.92B	6.09B
Cash, Cash Equivalents and Short-Term Investments	2.27B	2.14B	1.75B	1.81B	1.36B
Total Debt	671.35M	840.94M	1.10B	1.04B	373.00M
Total Liabilities	2.16B	2.23B	2.42B	2.56B	1.69B
Stockholders Equity	4.87B	4.63B	4.57B	4.36B	4.40B
Cash Flow
Free Cash Flow	459.85M	899.84M	285.69M	251.13M	320.31M
Operating Cash Flow	686.40M	952.55M	329.49M	641.46M	519.32M
Investing Cash Flow	-111.49M	-82.05M	545.84M	-1.16B	-239.76M
Financing Cash Flow	-443.83M	-479.71M	-340.95M	363.95M	13.26M

C.E.Management Integrated Laboratory Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 453.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6171, the sentiment is Positive. The current price of 453 is above the 20-day moving average (MA) of 430.60, above the 50-day MA of 386.22, and above the 200-day MA of 340.31, indicating a bullish trend. The MACD of 22.95 indicates Positive momentum. The RSI at 61.37 is Neutral, neither overbought nor oversold. The STOCH value of 28.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6171.

C.E.Management Integrated Laboratory Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1997	80 Outperform	¥5.81B	7.72		2.56%	-3.62%	27.31%
6171	77 Outperform	¥6.45B	18.07		2.65%	2.77%	96.98%
1844	73 Outperform	¥14.98B	29.72		1.25%	7.06%	38.55%
3267	73 Outperform	¥4.82B	8.72		1.21%	80.36%	14571.43%
1758	72 Outperform	¥4.76B	17.72		2.47%	-7.48%	9.38%
1897	71 Outperform	¥6.09B	38.13		1.78%	-32.43%	-64.26%
Sector *	59 Neutral	AU$1.63B	11.13	-5.90%	3.58%	9.76%	6.86%

C.E.Management Integrated Laboratory Co., Ltd. Corporate Events

C.E.Management Integrated Laboratory Reports Q1 2025 Financial Results

C.E.Management Integrated Laboratory Co., Ltd. reported its consolidated financial results for the first quarter of 2025, showing a slight decrease in net sales compared to the previous year. However, the company experienced an increase in operating profit and profit attributable to owners, indicating improved efficiency and profitability. The company’s financial position remains strong with a high equity ratio, and it maintains a consistent dividend forecast, reflecting stability and confidence in future performance.